Wednesday, August 10, 2022

TOPIC

DCGI

Studies suggest COVAXIN booster dose highly effective against Omicron and Delta variant: Details

Booster dose of COVAXIN is safe and may be necessary to ensure persistent immunity to prevent breakthrough infections.

DCGI grants emergency use approval to Bharat Biotech’s Covaxin for minors aged 12 to 18

DCGI has granted emergency use approval for Bharat Biotech's Covaxin for people in the age group 12 years to 18 years.

Zydus-Cadila’s ZyCoV-D becomes sixth vaccine to receive EUA in India, world’s first DNA based Covid-19 vaccine, will need 3 doses: Details

Zydus-Cadila ZyCoV-D Covid-19 vaccine has received Emergency Use Authorization (EUA) from the DCGI.

DCGI approves study at CMC Vellore to test efficacy of mixing doses of Covaxin and Covishield vaccines

CMC Vellore will conduct a study and clinical trial to determine if a person can take two different vaccine shots of Covidshield and Covaxin to complete the vaccination course.

Zydus Cadila applies for emergency use approval for its ZyCov-D vaccine, ready to produce 5 crore doses by 2021 end

Sharvil Patel, MD, Cadila Healthcare said, "As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against Covid-19".

Latest News

Recently Popular

Connect with us

255,564FansLike
592,838FollowersFollow
27,500SubscribersSubscribe